Firms & Funds Canada’s biotech boom continues with Repare’s $68 mln Series A, Zymeworks IPO Kirk Falconer - 22 June 2017 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
